Sensus Healthcare Q3 2024 revenue doubles to $8.8M; net income of $0.07 per diluted share

Sensus Healthcare, Inc.

2024-Q3 EPS reported $0.31 revenue$28,741,000

Revenue $8.8M (+127% YoY); net income $1.2M vs net loss $1.5M in Q3 2023.
Shipped 27 systems (11 in Q3 2023); cash $22.6M, no debt.
Adjusted EBITDA $1.6M (negative $1.7M a year ago).
Signed Fair Deal Agreement with Platinum Dermatology (130+ clinics); 22 agreements since March 2024.
Sold SRT system to Providence Swedish Hospital; expects recurring revenue from Fair Deal Agreements in 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.